APO Research
Talk to an analyst

APO RESEARCH · REPORT

Decitabine Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Decitabine Drug Market Outlook and Growth Opportunities 2026

22 December 2025199 pages

Choose your research edition.

Industry ResearchDecitabine Drug Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Decitabine Drug Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Decitabine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decitabine Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Decitabine Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Decitabine Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Decitabine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Decitabine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Decitabine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Decitabine Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Decitabine Drug market include Sun Pharmaceutical, Sandoz, Otsuka Pharmaceutical, Lupin, Dr Reddy's Laboratories, Cipla and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Decitabine Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Decitabine Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Decitabine Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Decitabine Drug market.

Decitabine Drug Segment by Company

Sun Pharmaceutical

Sandoz

Otsuka Pharmaceutical

Lupin

Dr Reddy's Laboratories

Cipla

Accord Healthcare

Decitabine Drug Segment by Type

Dacogen

Generic

Decitabine Drug Segment by Application

Hospital

Drug store

Decitabine Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Decitabine Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Decitabine Drug key companies, revenue, market share, and recent developments.

3. To split the Decitabine Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Decitabine Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Decitabine Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Decitabine Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decitabine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decitabine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decitabine Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Decitabine Drug industry.

Chapter 3: Detailed analysis of Decitabine Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Decitabine Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Decitabine Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Decitabine Drug Industry Trends Table 2. Decitabine Drug Industry Drivers Table 3. Decitabine Drug Industry Opportunities and Challenges Table 4. Decitabine Drug Industry Restraints Table 5. Global Decitabine Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Decitabine Drug Revenue Share by Company (2021-2026) Table 7. Global Decitabine Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Decitabine Drug Key Company Manufacturing Base & Headquarters Table 9. Global Decitabine Drug Company, Product Type & Application Table 10. Global Decitabine Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Decitabine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Dacogen Table 15. Significant Companies of Generic Table 16. Global Decitabine Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Decitabine Drug Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Decitabine Drug Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Decitabine Drug Sales Value Share by Type (2021-2026) Table 20. Global Decitabine Drug Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Drug store Table 23. Global Decitabine Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Decitabine Drug Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Decitabine Drug Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Decitabine Drug Sales Value Share by Application (2021-2026) Table 27. Global Decitabine Drug Sales Value Share by Application (2027-2032) Table 28. Global Decitabine Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Decitabine Drug Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Decitabine Drug Sales Value Share by Region (2021-2026) Table 31. Global Decitabine Drug Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Decitabine Drug Sales Value Share by Region (2027-2032) Table 33. Global Decitabine Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Decitabine Drug Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Decitabine Drug Sales Value Market Share by Country (2021-2026) Table 36. Global Decitabine Drug Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Decitabine Drug Sales Value Market Share by Country (2027-2032) Table 38. Sun Pharmaceutical Company Information Table 39. Sun Pharmaceutical Business Overview Table 40. Sun Pharmaceutical Decitabine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Sun Pharmaceutical Decitabine Drug Product Portfolio Table 42. Sun Pharmaceutical Recent Development Table 43. Sandoz Company Information Table 44. Sandoz Business Overview Table 45. Sandoz Decitabine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Sandoz Decitabine Drug Product Portfolio Table 47. Sandoz Recent Development Table 48. Otsuka Pharmaceutical Company Information Table 49. Otsuka Pharmaceutical Business Overview Table 50. Otsuka Pharmaceutical Decitabine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Otsuka Pharmaceutical Decitabine Drug Product Portfolio Table 52. Otsuka Pharmaceutical Recent Development Table 53. Lupin Company Information Table 54. Lupin Business Overview Table 55. Lupin Decitabine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Lupin Decitabine Drug Product Portfolio Table 57. Lupin Recent Development Table 58. Dr Reddy's Laboratories Company Information Table 59. Dr Reddy's Laboratories Business Overview Table 60. Dr Reddy's Laboratories Decitabine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Dr Reddy's Laboratories Decitabine Drug Product Portfolio Table 62. Dr Reddy's Laboratories Recent Development Table 63. Cipla Company Information Table 64. Cipla Business Overview Table 65. Cipla Decitabine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Cipla Decitabine Drug Product Portfolio Table 67. Cipla Recent Development Table 68. Accord Healthcare Company Information Table 69. Accord Healthcare Business Overview Table 70. Accord Healthcare Decitabine Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Accord Healthcare Decitabine Drug Product Portfolio Table 72. Accord Healthcare Recent Development Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Decitabine Drug Product Image Figure 2. Global Decitabine Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Decitabine Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Decitabine Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Dacogen Image Figure 8. Generic Image Figure 9. Global Decitabine Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Decitabine Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Decitabine Drug Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Drug store Image Figure 14. Global Decitabine Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Decitabine Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Decitabine Drug Sales Value Share by Application (2021-2032) Figure 17. Global Decitabine Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Decitabine Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Decitabine Drug Sales Value (2021-2032) & (US$ Million) Figure 20. North America Decitabine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Decitabine Drug Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Decitabine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Decitabine Drug Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Decitabine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Decitabine Drug Sales Value (2021-2032) & (US$ Million) Figure 26. South America Decitabine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Decitabine Drug Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Decitabine Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Decitabine Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Decitabine Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Decitabine Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Dacogen
  • Generic
Applications
  • Hospital
  • Drug store
Companies covered
  • Sun Pharmaceutical
  • Sandoz
  • Otsuka Pharmaceutical
  • Lupin
  • Dr Reddy's Laboratories
  • Cipla
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Decitabine Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Decitabine Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Decitabine Drug Market Dynamics
  1. 2.1 Decitabine Drug Industry Trends
  2. 2.2 Decitabine Drug Industry Drivers
  3. 2.3 Decitabine Drug Industry Opportunities and Challenges
  4. 2.4 Decitabine Drug Industry Restraints
3 Decitabine Drug Market by Company
  1. 3.1 Global Decitabine Drug Company Revenue Ranking in 2025
  2. 3.2 Global Decitabine Drug Revenue by Company (2021-2026)
  3. 3.3 Global Decitabine Drug Company Ranking (2024-2026)
  4. 3.4 Global Decitabine Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Decitabine Drug Company Product Type and Application
  6. 3.6 Global Decitabine Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Decitabine Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Decitabine Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Decitabine Drug Market by Type
  1. 4.1 Decitabine Drug Type Introduction
  2. 4.1.1 Dacogen
  3. 4.1.2 Generic
  4. 4.2 Global Decitabine Drug Sales Value by Type
  5. 4.2.1 Global Decitabine Drug Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Decitabine Drug Sales Value by Type (2021-2032)
  7. 4.2.3 Global Decitabine Drug Sales Value Share by Type (2021-2032)
5 Decitabine Drug Market by Application
  1. 5.1 Decitabine Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Decitabine Drug Sales Value by Application
  5. 5.2.1 Global Decitabine Drug Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Decitabine Drug Sales Value by Application (2021-2032)
  7. 5.2.3 Global Decitabine Drug Sales Value Share by Application (2021-2032)
6 Decitabine Drug Regional Value Analysis
  1. 6.1 Global Decitabine Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Decitabine Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Decitabine Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Decitabine Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Decitabine Drug Sales Value (2021-2032)
  7. 6.3.2 North America Decitabine Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Decitabine Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Decitabine Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Decitabine Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Decitabine Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Decitabine Drug Sales Value (2021-2032)
  16. 6.6.2 South America Decitabine Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Decitabine Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Decitabine Drug Sales Value Share by Country, 2025 VS 2032
7 Decitabine Drug Country-level Value Analysis
  1. 7.1 Global Decitabine Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Decitabine Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Decitabine Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Decitabine Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Decitabine Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Decitabine Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Decitabine Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Decitabine Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Decitabine Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Decitabine Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Decitabine Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Decitabine Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Decitabine Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Decitabine Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Decitabine Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Decitabine Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Decitabine Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Decitabine Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Decitabine Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Decitabine Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Decitabine Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Decitabine Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Decitabine Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Decitabine Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Decitabine Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Decitabine Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Decitabine Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Decitabine Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Decitabine Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Decitabine Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Decitabine Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Decitabine Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Decitabine Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Decitabine Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Decitabine Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical
  2. 8.1.1 Sun Pharmaceutical Company Information
  3. 8.1.2 Sun Pharmaceutical Business Overview
  4. 8.1.3 Sun Pharmaceutical Decitabine Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Decitabine Drug Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Decitabine Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Decitabine Drug Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Otsuka Pharmaceutical
  14. 8.3.1 Otsuka Pharmaceutical Company Information
  15. 8.3.2 Otsuka Pharmaceutical Business Overview
  16. 8.3.3 Otsuka Pharmaceutical Decitabine Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Otsuka Pharmaceutical Decitabine Drug Product Portfolio
  18. 8.3.5 Otsuka Pharmaceutical Recent Developments
  19. 8.4 Lupin
  20. 8.4.1 Lupin Company Information
  21. 8.4.2 Lupin Business Overview
  22. 8.4.3 Lupin Decitabine Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lupin Decitabine Drug Product Portfolio
  24. 8.4.5 Lupin Recent Developments
  25. 8.5 Dr Reddy's Laboratories
  26. 8.5.1 Dr Reddy's Laboratories Company Information
  27. 8.5.2 Dr Reddy's Laboratories Business Overview
  28. 8.5.3 Dr Reddy's Laboratories Decitabine Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dr Reddy's Laboratories Decitabine Drug Product Portfolio
  30. 8.5.5 Dr Reddy's Laboratories Recent Developments
  31. 8.6 Cipla
  32. 8.6.1 Cipla Company Information
  33. 8.6.2 Cipla Business Overview
  34. 8.6.3 Cipla Decitabine Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cipla Decitabine Drug Product Portfolio
  36. 8.6.5 Cipla Recent Developments
  37. 8.7 Accord Healthcare
  38. 8.7.1 Accord Healthcare Company Information
  39. 8.7.2 Accord Healthcare Business Overview
  40. 8.7.3 Accord Healthcare Decitabine Drug Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Accord Healthcare Decitabine Drug Product Portfolio
  42. 8.7.5 Accord Healthcare Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst